EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the Outcome

Raquel A Binder iD, Gavin F Fujimori, Catherine S Forconi, George W Reed, Leandro S Silva, Priya Saikumar Lakshmi, Amanda Higgins, Lindsey Cincotta, Protiva Dutta, Marie-Claire Salive, Virginia Mangolds, Otuwe Anya und 18 weitere

The Journal of Infectious Diseases · 2023

DOI: 10.1093/infdis/jiac431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Raquel A Binder und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NCI Serological Sciences Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evaluating the performance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological assays and clearly articulating the utility of selected antigens, isotypes, and thresholds is crucial to understanding the prevalence of infection within selected communities.

Methods

This cross-sectional study, implemented in 2020, screened PCR–confirmed coronavirus disease 2019 patients (n = 86), banked prepandemic and negative samples (n = 96), healthcare workers and family members (n = 552), and university employees (n = 327) for anti–SARS-CoV-2 receptor-binding domain, trimeric spike protein, and nucleocapsid protein immunoglobulin (Ig)G and IgA antibodies with a laboratory-developed enzyme-linked immunosorbent assay and tested how antigen, isotype and threshold choices affected the seroprevalence outcomes. The following threshold methods were evaluated: (i) mean + 3 standard deviations of the negative controls; (ii) 100% specificity for each antigen-isotype combination; and (iii) the maximal Youden index.

Results

We found vastly different seroprevalence estimates depending on selected antigens and isotypes and the applied threshold method, ranging from 0.0% to 85.4%. Subsequently, we maximized specificity and reported a seroprevalence, based on more than one antigen, ranging from 9.3% to 25.9%.

Conclusions

This study revealed the importance of evaluating serosurvey tools for antigen-, isotype-, and threshold-specific sensitivity and specificity, to interpret qualitative serosurvey outcomes reliably and consistently across studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansSeroepidemiologic StudiesCross-Sectional StudiesNucleocapsid ProteinsEnzyme-Linked Immunosorbent AssaySensitivity and SpecificityImmunoglobulin GAntibodies, ViralSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

ELISAMassachusettsSARS-CoV-2Youden indexantigenisotypeserosurveythreshold

Substanzen

Nucleocapsid ProteinsImmunoglobulin GAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Department of Emergency Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Department of Pathology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, USA.
  • Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.

ORCID-Profile: Raquel A Binder, Peter O Oluoch, Galit Alter

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NCI Serological Sciences Network
  • National Institutes of Health

Zitieren

APA

Binder, R. A., Fujimori, G. F., Forconi, C. S., Reed, G. W., Silva, L. S., Lakshmi, P. S., Higgins, A., Cincotta, L., Dutta, P., Salive, M. C., Mangolds, V., Anya, O., Calvo Calle, J. M., Nixon, T., Tang, Q., Wessolossky, M., Wang, Y., Ritacco, D. A., Bly, C. S., …, & Moormann, A. M. (2023). SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the Outcome. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac431

Vancouver

Binder RA, Fujimori GF, Forconi CS, Reed GW, Silva LS, Lakshmi PS, et al. SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the Outcome. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiac431

BibTeX
@article{Binder2023,
  author = {Binder, Raquel A and Fujimori, Gavin F and Forconi, Catherine S and Reed, George W and Silva, Leandro S and Lakshmi, Priya Saikumar and Higgins, Amanda and Cincotta, Lindsey and Dutta, Protiva and Salive, Marie-Claire and Mangolds, Virginia and Anya, Otuwe and Calvo Calle, J Mauricio and Nixon, Thomas and Tang, Qiushi and Wessolossky, Mireya and Wang, Yang and Ritacco, Dominic A and Bly, Courtney S and Fischinger, Stephanie and Atyeo, Caroline and Oluoch, Peter O and Odwar, Boaz and Bailey, Jeffrey A and Maldonado-Contreras, Ana and Haran, John P and Schmidt, Aaron G and Cavacini, Lisa and Alter, Galit and Moormann, Ann M},
  title = {SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the Outcome},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1093/infdis/jiac431}
}
Kostenlos starten →